Enhances the firm’s ability to serve life sciences and technology companies in Colorado and beyond ...

Foley Hoag advised Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing surgical solutions for the restoration of peripheral nerve function, in its $200 million acquisition of ...

Foley Hoag has been named an Intimidating Opponent in Litigation for 2027 by BTI, a list of 92 law firms singled out by corporate counsel as “firms they least want to see on the other side.” Firms ...

Foley Hoag has been named one of Law360's 2026 Prestige Leaders. The firm placed #83 in this year's ranking, up from #98 in 2025. The annual Prestige Leaders ranking names the top 100 law firms the ...

For the second time in less than four weeks, a federal judge has ruled that New York’s Climate Change Superfund Act (“the Climate Act”) is unconstitutional.

Every week, a lab somewhere feeds a protein sequence into AlphaFold Server and gets back a structure prediction that used to take months to solve by X-ray crystallography. Chemists run candidate ...

Biologics are one of the fastest-growing areas of pharmaceutical development, and more companies are conducting initial clinical work outside the United States. Jurisdictions such as China, Australia, ...

The data is striking. According to FDA, the United States has lost approximately 10% of its global share of Phase 1 clinical trials since 2015 (FDA Webinar). China surpassed the United States in Phase ...

The United States Court of Appeals for the Federal Circuit has denied Eli Lilly and Company's petition for rehearing en banc ...